Purchase

Multi-rAb CoraLite® Plus 555-Goat Anti-Rabbit Recombinant Secondary Antibody (H+L)

Multi-rAb Goat Anti-rabbit recombinant secondary antibody is a mixture of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on rabbit IgG heavy and light chain.

Applications

IF, FC

Conjugate

CoraLite® Plus 555

Host

Goat

Reactivity

Rabbit

Cat no : RGAR003


Product Information

RGAR003 targets Rabbit IgG (H+L) in FC and IF. It is higly specific to rabbit IgG and shows minimal reactivity for mouse, rat, human, pig and bovine IgGs.

Concentration 0.5 mg/mL
Applications IF, FC
Host Species Goat
Species Reactivity Rabbit
Physical State Liquid
Suggested Dilution Range 1:200-1:1000 for IF and FC
Purity The antibody was purified from culture media supernatant by immunoaffinity chromatography using Protein G beads.
Storage Buffer PBS with 50% glycerol, 10 mg/mL BSA, 0.1% Proclin-300, pH 7.4.
Storage Instructions Store at -20°C. Stable for one year after shipment.
FluorophoreCoraLite® Plus 555, Amax=554 nm, Emax=570 nm
ClonalityMulticlonal recombinant
RRIDAB_3073507
NoteThis product is for research use only,not for diagnostic or therapeutic use.

Background

Multi-rAb Recombinant Secondary Antibodies are mixtures of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the same IgG. Each recombinant clone in the final multiclonal mixture is carefully selected after rigorous characterization and screening to ensure the highest level of performance. ​The selected clones are mixed in various combinations, each of which is then functionally characterized in multiple applications to select the final multiclonal mixture with optimal performance. Each lot of Multi-rAb Secondary Antibodies is produced by mixing the same high performing recombinant clones every time to ensure that they have high batch-to-batch consistency, which in turn results in high reproducibility of experimental data.

Publications

Title

Nat Nanotechnol

A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy

Authors - Yanqin Zhang